• Nolvadex 20 SWISSPHARMA 20mg/30tab

Nolvadex 20 SWISSPHARMA 20 mg — 30 Tablets

Product Overview

Nolvadex 20 SWISSPHARMA Online Poland is described as a pack of 30 tablets, each labelled as containing 20 mg of tamoxifen. Tamoxifen is a prescription medicine in a group known as selective oestrogen receptor modulators (SERMs). It acts on oestrogen receptors, with effects that vary between tissues. In breast tissue, it can block or modify the action of oestrogen, which may be relevant in treating certain oestrogen-sensitive breast cancers.

Product names, formulations, manufacturers, ingredients and regulatory approvals can vary between countries. The name shown here does not, by itself, confirm a product’s authenticity, manufacturer or approval status. Before using any pack, check its original packaging and official patient leaflet, and ask a licensed pharmacist to verify it if you have concerns.

What Is Tamoxifen Used For?

Tamoxifen may be prescribed by a specialist for certain types of breast cancer, including some cancers whose growth is influenced by hormones. Depending on the diagnosis and local approvals, it may form part of treatment after surgery or other cancer therapy, or be used when cancer has spread. A clinician may also consider it for other approved uses in particular circumstances.

Whether tamoxifen is appropriate depends on factors such as the cancer’s characteristics, test results, previous treatment, medical history and individual risk factors. It is not suitable for every type of breast cancer or every patient. Only the treating specialist can explain the purpose of treatment and how it fits into an individual care plan.

Strength and Pack Details

The “20 mg” label indicates the stated amount of tamoxifen in each tablet; “30 tablets” refers to the stated pack quantity. These details should be confirmed on the specific packaging and in its leaflet. Appearance, inactive ingredients, manufacturer information and pack design may differ across markets.

Do not use tablets if the pack is damaged, the seal or labelling appears altered, or the product name, strength, batch details or expiry date cannot be clearly checked. Obtain prescription medicines through a licensed pharmacy or another authorised source. If the product does not match what was prescribed, ask a pharmacist or prescriber before taking it.

Use Under Medical Supervision

Tamoxifen should be used only when prescribed by a qualified healthcare professional. The prescriber determines the dose, treatment schedule and duration based on the individual treatment plan. Follow the prescription and the official leaflet supplied with your medicine. Do not start treatment, change how you take it, take extra tablets or stop treatment without first speaking with your prescriber.

If you miss a dose or are uncertain whether you have taken one, consult the leaflet or contact your pharmacist or healthcare professional for advice. Do not take an additional tablet to make up for a missed dose unless you are specifically instructed to do so. Keep scheduled appointments, as your care team may need to review your treatment and monitor your health.

Information to Share Before Treatment

Before starting tamoxifen, tell your doctor or pharmacist about your medical history, allergies and all medicines or supplements you use. Include prescription and non-prescription medicines, vitamins and herbal products. Some medicines can affect how tamoxifen works or increase the chance of unwanted effects. Your healthcare professional should review your complete medication list, especially if another clinician starts or changes a medicine during treatment.

Tell your prescriber if you have a history of blood clots, stroke, liver problems, eye problems or other significant health conditions. Discuss pregnancy, plans to become pregnant and breastfeeding before treatment. Tamoxifen may harm an unborn baby and is generally avoided during pregnancy. Follow your clinician’s advice about contraception and pregnancy testing where applicable; do not rely on this general description for individual instructions.

Possible Side Effects and Important Risks

Side effects can occur, although not everyone experiences them. The official leaflet for the exact product provides the full list and frequency information. Some people may experience hot flushes, sweating, nausea, changes in menstrual periods, vaginal symptoms or tiredness. Report persistent or troublesome symptoms to your healthcare professional.

Tamoxifen can also be associated with serious risks, including blood clots. Seek urgent medical attention for symptoms such as sudden chest pain, difficulty breathing, or painful swelling in one leg. Unusual vaginal bleeding, sudden vision changes, or other severe or unexpected symptoms should also be assessed promptly. These examples are not a complete list; read the leaflet and discuss your personal risk factors with your prescriber.

Monitoring During Treatment

Your healthcare team may recommend follow-up appointments or tests, depending on your diagnosis and treatment plan. Attend these appointments and tell your care team about new symptoms or changes in your health. Ask your specialist what monitoring is appropriate for you and how to report concerns between visits. Do not delay seeking help for severe or sudden symptoms while waiting for a routine appointment.

Storage and Disposal

Store the tablets as directed on the packaging and in the patient leaflet. Keep them in their original pack if instructed, away from conditions that could damage the medicine, and out of the sight and reach of children. Do not use the product after its expiry date. Ask a pharmacist how to dispose of unused or expired tablets safely; follow local medicine-disposal guidance.

General Information

Nolvadex 20 SWISSPHARMA 20 mg — 30 Tablets should be treated as a prescription-medicine listing, not as a supplement or a product for self-directed use. The approved uses, legal status and product details may vary by country. Verify the specific pack with a licensed pharmacist and rely on its current official leaflet and your specialist’s advice.

This description is for general informational purposes only. It does not confirm the authenticity or regulatory approval of a particular pack and does not replace the official patient leaflet, a prescription, or advice from a doctor or pharmacist.


Write a review

Note: HTML is not translated!
    Bad           Good

Nolvadex 20 SWISSPHARMA 20mg/30tab

  • Brand: SWISSPHARMA
  • Product Code: Tamoxifen citrate
  • Availability: In Stock
  • $40.32


Available Options


Tags: Nolvadex 20 SWISSPHARMA 20mg/30tab